Lillicrap D - Search Results

1

Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis.

Oomen I, Camelo RM, Rezende SM, Voorberg J, Mancuso ME, Oldenburg J, Carcao M, Matino D, Lillicrap D, Fischer K, Fijnvandraat K, Gouw SC; International Genetic and clinical determinants of the Outcome of Immune Tolerance Induction (GO-ITI) study group. Oomen I, et al. Among authors: lillicrap d. Res Pract Thromb Haemost. 2022 Dec 20;7(1):100020. doi: 10.1016/j.rpth.2022.100020. eCollection 2023 Jan. Res Pract Thromb Haemost. 2022. PMID: 36891524 Free PMC article.

2

A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?

Valentino LA, Ozelo MC, Herzog RW, Key NS, Pishko AM, Ragni MV, Samelson-Jones BJ, Lillicrap D. Valentino LA, et al. Among authors: lillicrap d. J Thromb Haemost. 2023 Nov;21(11):3033-3044. doi: 10.1016/j.jtha.2023.05.011. Epub 2023 May 22. J Thromb Haemost. 2023. PMID: 37225021 Free article. Review.

3

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure.

Christopherson PA, Haberichter SL, Flood VH, Sicking UO, Abshire TC, Montgomery RR; Zimmerman Program Investigators. Christopherson PA, et al. Res Pract Thromb Haemost. 2022 Oct 5;6(7):e12807. doi: 10.1002/rth2.12807. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36381287 Free PMC article.

4

The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis.

Swystun LL, Michels A, Lillicrap D. Swystun LL, et al. Among authors: lillicrap d. J Thromb Haemost. 2023 Aug;21(8):2007-2019. doi: 10.1016/j.jtha.2023.04.014. Epub 2023 Apr 19. J Thromb Haemost. 2023. PMID: 37085036 Review.

5

Artificial intelligence, science, and learning.

Lillicrap D, Morrissey JH. Lillicrap D, et al. J Thromb Haemost. 2023 Apr;21(4):709. doi: 10.1016/j.jtha.2023.01.026. J Thromb Haemost. 2023. PMID: 36990517 Free article. No abstract available.

6

Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation.

Swystun LL, Lillicrap D. Swystun LL, et al. Among authors: lillicrap d. Pharmgenomics Pers Med. 2023 Mar 24;16:239-252. doi: 10.2147/PGPM.S383221. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 36998673 Free PMC article. Review.

7

Priming the translational pipeline for hemostasis therapies.

Lillicrap D, Morrissey JH. Lillicrap D, et al. J Thromb Haemost. 2023 Aug;21(8):2005-2006. doi: 10.1016/j.jtha.2023.06.002. J Thromb Haemost. 2023. PMID: 37468172 No abstract available.

8

Corrigendum to To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia [J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485].

Othman M, Baker AT, Gupalo E, Elsebaie A, Bliss CM, Rondina MT, Lillicrap D, Parker AL. Othman M, et al. Among authors: lillicrap d. J Thromb Haemost. 2023 Apr;21(4):1066. doi: 10.1016/j.jtha.2023.01.022. Epub 2023 Feb 1. J Thromb Haemost. 2023. PMID: 36737373 Free PMC article. No abstract available.

9

The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice.

Choi SJ, Dwyer CN, Rapkin L, Cormier M, Hindmarch CCT, Nesbitt K, Michels A, Hopman W, Swystun LL, Lillicrap D. Choi SJ, et al. Among authors: lillicrap d. J Thromb Haemost. 2023 Mar;21(3):586-598. doi: 10.1016/j.jtha.2022.11.022. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696220 Free article.

10

[No title available]

[No authors listed] [No authors listed] PMID: 36700494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page